Comments for Dolcera Musings http://blogs.dolcera.com/samir Thoughts on the world around Dolcera Fri, 18 May 2012 06:02:22 +0000 http://wordpress.org/?v=2.3.1 Comment on Big decision on the Myriad gene patenting case by Harit http://blogs.dolcera.com/samir/2010/03/29/big-decision-on-the-myriad-gene-patenting-case/#comment-198 Harit Tue, 30 Mar 2010 06:25:52 +0000 http://blogs.dolcera.com/samir/2010/03/29/big-decision-on-the-myriad-gene-patenting-case/#comment-198 This is a text book example of patenting the cancer related genes and the aftermaths: European Parliament resolution on the patenting of BRCA1 and BRCA2 ('breast cancer') genes suggest that,the granting of similar patents by the EPO could create a monopoly for the firm in question within the European Union as well, which could seriously impede or even completely prevent the further use of existing cheaper and more effective tests for the breast cancer genes BRCA1 and BRCA2; whereas this development could have an unacceptable detrimental effect on the women concerned and constitute a serious drain on the funds of public health services; whereas moreover it could seriously impede the development of and research into new methods of diagnosis. The EPO granted patents on BRCA1 to Myriad Genetics in the form of Patent No 699754 of 10 January 2001 and Patent No 705 903 of 23 May 2001 and is considering granting further patents on the breast cancer genes BRCA1 and BRCA2. This is a text book example of patenting the cancer related genes and the aftermaths:

European Parliament resolution on the patenting of BRCA1 and BRCA2 (’breast cancer’) genes suggest that,the granting of similar patents by the EPO could create a monopoly for the firm in question within the European Union as well, which could seriously impede or even completely prevent the further use of existing cheaper and more effective tests for the breast cancer genes BRCA1 and BRCA2; whereas this development could have an unacceptable detrimental effect on the women concerned and constitute a serious drain on the funds of public health services; whereas moreover it could seriously impede the development of and research into new methods of diagnosis.

The EPO granted patents on BRCA1 to Myriad Genetics in the form of Patent No 699754 of 10 January 2001 and Patent No 705 903 of 23 May 2001 and is considering granting further patents on the breast cancer genes BRCA1 and BRCA2.

]]> Comment on Why technology wins by Jhumur http://blogs.dolcera.com/samir/2008/11/04/why-technology-wins/#comment-49 Jhumur Sun, 14 Dec 2008 05:09:43 +0000 http://blogs.dolcera.com/samir/2008/11/04/why-technology-wins/#comment-49 True....I completely agree with the point he has made. True….I completely agree with the point he has made.

]]>